Royalty Pharma plc (NASDAQ:RPRX) has a 12-month trailing P/E ratio of 28.93, and a growth ratio of 3.62. The stock’s Relative Strength Index (RSI) is
Royalty Pharma plc (NASDAQ:RPRX) previous close was $46.63 while the outstanding shares total 383.99M. The firm has a 12-month trailing P/E ratio of 30.15, and
Royalty Pharma plc (NASDAQ:RPRX) shares traded higher over the last trading session, gaining 3.50% on 06/04/21. The shares fell to a low of $43.35 before
Royalty Pharma plc (NASDAQ:RPRX) shares fell to a low of $40.01 before closing at $40.12. Intraday shares traded counted 0.84 million, which was 66.87% higher
Royalty Pharma plc (NASDAQ:RPRX) previous close was $40.72 while the outstanding shares total 383.99M. The firm has a 12-month trailing P/E ratio of 27.01, and
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
